BD's (BDX) latest launch is expected to advance its vision of a One-Stick Hospital Stay by improving the first-stick success in IV placements.

DivHut Portfolio Update: March 2023

12:11am, Wednesday, 12'th Apr 2023
The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book. Earning $1,893.81 represents 12.6% year o

My Dividend Growth Portfolio - Q1 2023 Summary

01:26am, Thursday, 06'th Apr 2023
In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its
BDX vs. WST: Which Stock Is the Better Value Option?
I'd argue there's never been a better time to consider investing in dividend aristocrats. Volatility remains very high in the overall market, with a destabilized banking sector.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Here are two Dividend Aristocrats that are top-rated Zacks stocks at the moment and can offer unique exposure and diversification to investors' portfolios.
BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.
While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of t

3 Stocks to Buy for Consistent Dividend Growth

05:34pm, Friday, 10'th Mar 2023
Some of these companies have been around for over 100 years and have seen all imaginable economic environments
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.
BDX vs. ALGN: Which Stock Is the Better Value Option?
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
FRANKLIN LAKES, N.J. , March 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays G
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its combination at-home COVID-19 and a flu test
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE